Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Crea

Showing results (41-50 of 1,388) with videos related to

Pageof 139
Sort By:
European Heart Journal|May 14, 2022
New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5Filippo Crea
European Heart Journal|July 21, 2021
Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and CharybdisFilippo Crea
European Heart Journal|January 11, 2021
The new frontiers in prevention: from sports cardiology to spaceflight, and back to earth with cardiovascular disease and cancerFilippo Crea
European Heart Journal|October 8, 2022
Antithrombotic treatment: how to navigate between the Scylla of thrombosis and the Charybdis of bleeding?Filippo Crea
European Heart Journal|August 31, 2023
TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?Filippo Crea
European Heart Journal|January 21, 2021
Risk stratification and treatment of acute and chronic coronary syndromes: focus on angina without obstructive coronary arteries, refractory angina, lipids, and clonal haematopoiesisFilippo Crea
European Heart Journal|March 6, 2021
How inflammation heats the heartFilippo Crea
European Heart Journal|February 3, 2021
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemicFilippo Crea
European Heart Journal|December 14, 2021
An update on triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular diseaseFilippo Crea
European Heart Journal|November 7, 2021
New targets in vascular biology and new challenges in vascular medicineFilippo Crea
Pageof 139

Showing results (41-50 of 1,388) with videos related to

Sort By:
Pageof 139
European Heart Journal|May 14, 2022
New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5Filippo Crea
European Heart Journal|July 21, 2021
Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and CharybdisFilippo Crea
European Heart Journal|January 11, 2021
The new frontiers in prevention: from sports cardiology to spaceflight, and back to earth with cardiovascular disease and cancerFilippo Crea
European Heart Journal|October 8, 2022
Antithrombotic treatment: how to navigate between the Scylla of thrombosis and the Charybdis of bleeding?Filippo Crea
European Heart Journal|August 31, 2023
TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?Filippo Crea
European Heart Journal|January 21, 2021
Risk stratification and treatment of acute and chronic coronary syndromes: focus on angina without obstructive coronary arteries, refractory angina, lipids, and clonal haematopoiesisFilippo Crea
European Heart Journal|March 6, 2021
How inflammation heats the heartFilippo Crea
European Heart Journal|February 3, 2021
Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemicFilippo Crea
European Heart Journal|December 14, 2021
An update on triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular diseaseFilippo Crea
European Heart Journal|November 7, 2021
New targets in vascular biology and new challenges in vascular medicineFilippo Crea
Pageof 139